Device Firms Seek More Exemptions, Pricing Flexibility For Oncoming Excise Tax

Written comments were due May 7 on the Internal Revenue Service’s proposed regulation to implement a 2.3% excise tax on device sales in the lead-up to a May 16 public hearing.

More from Archive

More from Medtech Insight